UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

PloS one, 2016-06, Vol.11 (6), p.e0157368-e0157368

2016

Volltextzugriff (PDF)

Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes

The Journal of pathology, 2014-01, Vol.232 (2), p.142-150

2014

Volltextzugriff (PDF)

Subtyping of triple‐negative breast cancer: Implications for therapy

Cancer, 2015-01, Vol.121 (1), p.8-16

2015

Volltextzugriff (PDF)

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

The Journal of clinical investigation, 2011-07, Vol.121 (7), p.2750-2767

2011

Volltextzugriff (PDF)

New Strategies for Triple-Negative Breast Cancer—Deciphering the Heterogeneity

Clinical cancer research, 2014-02, Vol.20 (4), p.782-790

2014

Volltextzugriff (PDF)

Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes

Nature communications, 2021-11, Vol.12 (1), p.6276-6276, Article 6276

2021

Volltextzugriff (PDF)

Clinical implications of molecular heterogeneity in triple negative breast cancer

Breast (Edinburgh), 2015-11, Vol.24 (2), p.S36-S40

2015

Volltextzugriff (PDF)

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

Clinical cancer research, 2013-10, Vol.19 (19), p.5533-5540

2013

Volltextzugriff (PDF)

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

Breast cancer research : BCR, 2014-08, Vol.16 (4), p.406-406, Article 406

2014

Volltextzugriff (PDF)

p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network

Cell reports (Cambridge), 2016-03, Vol.14 (10), p.2289-2300

2016

Volltextzugriff (PDF)

A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments

PloS one, 2015-05, Vol.10 (5), p.e0125482

2015

Volltextzugriff (PDF)

Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes

Nature communications, 2021-08, Vol.12 (1), p.5184-5184, Article 5184

2021

Volltextzugriff (PDF)

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer

Cancer informatics, 2012-01, Vol.2012 (11), p.147-156

2012

Volltextzugriff (PDF)

Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (15), p.7589-7597

2006

Volltextzugriff (PDF)

p73 regulates epidermal wound healing and induced keratinocyte programming

PloS one, 2019-06, Vol.14 (6), p.e0218458-e0218458

2019

Volltextzugriff (PDF)

Tissue-specific expression of p73 and p63 isoforms in human tissues

Cell death & disease, 2021-07, Vol.12 (8), p.745-745, Article 745

2021

Volltextzugriff (PDF)

Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer

Molecular cancer therapeutics, 2016-11, Vol.15 (11), p.2598-2608

2016

Volltextzugriff (PDF)

Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies

Cancer research (Chicago, Ill.), 2016-08, Vol.76 (16), p.4850-4860

2016

Volltextzugriff (PDF)

MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer

Nature communications, 2023-09, Vol.14 (1), p.5665-21, Article 5665

2023

Volltextzugriff (PDF)

mTOR regulates autophagy-associated genes downstream of p73

Autophagy, 2009-01, Vol.5 (1), p.114-116

2009

Volltextzugriff (PDF)

Triple-negative breast cancer: molecular subtypes and new targets for therapy

American Society of Clinical Oncology educational book, 2015 (35), p.e31-e39

2015

Volltextzugriff (PDF)

Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation

Clinical cancer research, 2010-01, Vol.16 (2), p.681-690

2010

Volltextzugriff (PDF)

p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton

Cell death & disease, 2018-12, Vol.9 (12), p.1183-18, Article 1183

2018

Volltextzugriff (PDF)

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue

BMC cancer, 2017-04, Vol.17 (1), p.241-241, Article 241

2017

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Englisch
(193)
Japanisch
(37)

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Humans
(110)
Life Sciences & Biomedicine
(103)
Oncology
(57)
Female
(49)
Biological And Medical Sciences
(42)
Animals
(40)
Tumors
(30)
Cell Line, Tumor
(28)
Medical Sciences
(26)
Mice
(26)
Cell Biology
(25)
Breast Cancer
(24)
Cancer
(23)
Biochemistry & Molecular Biology
(20)
Mutation
(20)
Triple Negative Breast Neoplasms - Genetics
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)
Triple Negative Breast Neoplasms - Drug Therapy
(18)
Tumor Suppressor Protein P53 - Metabolism
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes

Subtyping of triple‐negative breast cancer: Implications for therapy

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

New Strategies for Triple-Negative Breast Cancer—Deciphering the Heterogeneity

Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes

Clinical implications of molecular heterogeneity in triple negative breast cancer

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network

A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets

Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer

Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis

p73 regulates epidermal wound healing and induced keratinocyte programming

Tissue-specific expression of p73 and p63 isoforms in human tissues

Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer

Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies

MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer

mTOR regulates autophagy-associated genes downstream of p73

Triple-negative breast cancer: molecular subtypes and new targets for therapy

Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation

p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue

Suchergebnisse filtern